Röchling: Boris Fröhlich neuer CEO des Medical-Geschäfts

Beim Kunststoffkonzern Röchling (Mannheim) wird Boris Fröhlich zum 1. Januar 2020 neuer CEO des Segments „Medical“. In der Leitung der Medizintechnik-Aktivitäten folgt er auf Prof. Dr. Hanns-Peter …
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
628